The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of approximately 9% during the forecast period. This growth is largely driven by the ...
The device-drug relationships can be very profitable to device companies; drug-eluting stent sales have rung up billions of dollars in sales annually. Yet, for these relationships to succeed, device ...
OAKLAND, Calif.--(BUSINESS WIRE)--SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001, today announced that the United States Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback